한글목차

세계의 MIS 천장관절 고정술 시장 규모는 2024년에 3억 6,500만 달러로 평가되었고, 2025-2031년의 예측 기간에 CAGR 12.7%로 성장하여 2031년까지 8억 4,200만 달러에 이를 것으로 예측됩니다.

본 보고서는 MIS 천장관절 고정술에 대한 최근 관세 조정과 국제적인 전략적 대응 조치에 대해 국경 간 산업 발자국, 자본 배분 패턴, 지역 경제의 상호 의존성, 공급망 재구축을 종합적으로 평가합니다.

천장관절 고정술은 안정화를 목적으로 장골(골반)을 척추(천골)에 고정하는 수술입니다. 외상, 감염, 암, 척추 불안정증 등 다양한 질환에 시행됩니다. 천장관절 고정술은 최소침습수술(MIS)로 시행될 수도 있고, 더 큰 절개와 긴 회복기간을 요하는 개복수술로 시행될 수도 있습니다. 경피적 천장관절 고정술은 MIS 접근법이며, 뼈 이식의 유무에 관계없이 체외에서 케이지나 나사를 이용한 기구를 삽입하여 고정을 달성합니다. 뼈 이식 및 기타 금속 임플란트 장치를 이용한 천장관절 고정술은 광범위한 시술이며, 일반적으로 다른 모든 통증 완화 방법이 실패한 경우 최후의 수단으로 간주됩니다.

MIS 천장관절 고정술 시장은 만성 요통의 원인으로 천장관절 기능장애에 대한 인식이 높아짐에 따라 꾸준히 성장하고 있습니다. SI-BONE, 메드트로닉, 지멘스, 지멘스 바이오메트 등 주요 업체들은 이미 확립된 임플란트 시스템과 풍부한 임상 데이터로 시장을 선도하고 있습니다. CoreLink와 VGI Medical과 같은 신생 기업들은 혁신적인 고정 기술과 개선된 임플란트 설계를 통해 차별화를 꾀하고 있습니다. 수술 시간 단축, 출혈량 감소, 빠른 회복으로 인해 외과 의사의 최소침습적 접근법 채택이 증가하고 있습니다. 향후 동향으로는 정확도 향상을 위한 내비게이션-로봇 가이던스 시스템의 통합과 융합 촉진을 위한 생물학적 증강이 주목됩니다.

이 보고서는 MIS 천장관절 고정술 세계 시장에 대해 총 판매량, 매출액, 가격, 주요 기업의 시장 점유율 및 순위에 초점을 맞추고 지역/국가, 유형 및 용도별 분석을 종합적으로 제시하는 것을 목표로 합니다.

MIS 천장관절 고정술 시장 규모 추정 및 예측은 판매량(천 단위) 및 매출액(백만 달러)으로 제시되며, 2024년을 기준 연도로 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 2024년부터 2031년까지의 예측 데이터를 제공합니다. 정량적, 정성적 분석을 통해 독자들이 MIS 천장관절 고정술 관련 사업 전략 및 성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 자사 포지셔닝 분석, 정보에 입각한 사업적 판단을 내리는데 도움을 드립니다.

시장 세분화

기업별

• SI-BONE
• Medtronic
• Zimmer Biomet
• Orthofix
• RTI Surgical
• Xtant Medical
• Globus Medical
• Life Spine
• CoreLink
• VGI Medical
• SIGNUS Medizintechnik

유형별 부문

• 저침습 수술
• 천장관절 고정술 개복 수술

용도별 부문

• 병원
• ASC

지역별

• 북미
  • 미국
  • 캐나다
• 아시아태평양
  • 중국
  • 일본
  • 한국
  • 동남아시아
  • 인도
  • 호주
  • 기타 아시아태평양
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 네덜란드
  • 북유럽 국가
  • 기타 유럽
• 라틴아메리카
  • 멕시코
  • 브라질
  • 기타 라틴아메리카
• 중동 및 아프리카
  • 튀르키예
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동 및 아프리카

영문목차

The global market for MIS Sacroiliac Joint Fusion was estimated to be worth US$ 365 million in 2024 and is forecast to a readjusted size of US$ 842 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on MIS Sacroiliac Joint Fusion cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Sacroiliac joint fusion is a surgical procedure which fuses the iliac bone (pelvis) to the spine (sacrum) for stabilization. It is performed for a variety of conditions including trauma, infection, cancer, and spinal instability. Sacroiliac joint fusion may be performed as a minimally invasive surgical (MIS) procedure or as an open surgical procedure requiring a larger incision and subsequent increased recovery time. Percutaneous SIJ fusion is a MIS approach in which instrumentation involving cages or screws, with or without bone graft, are placed percutaneously in order to achieve a fusion. Fusion of the SIJ, combined with bone grafts and other metal implant devices, is an extensive procedure; generally considered a salvage procedure when all other measures have failed to provide pain relief.

The MIS sacroiliac (SI) joint fusion market is growing steadily, driven by the rising recognition of sacroiliac joint dysfunction as a source of chronic lower back pain. Leading manufacturers like SI-BONE, Medtronic, and Zimmer Biomet dominate the space with well-established implant systems and extensive clinical validation. Emerging players such as CoreLink and VGI Medical are differentiating through innovative fixation techniques and improved implant designs. The market is witnessing increased surgeon adoption of minimally invasive approaches due to reduced operative time, lower blood loss, and quicker recovery. Future trends point to the integration of navigation and robotic guidance systems to enhance precision, as well as biologic augmentation to promote faster fusion.

This report aims to provide a comprehensive presentation of the global market for MIS Sacroiliac Joint Fusion, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of MIS Sacroiliac Joint Fusion by region & country, by Type, and by Application.

The MIS Sacroiliac Joint Fusion market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MIS Sacroiliac Joint Fusion.

Market Segmentation

By Company

• SI-BONE
• Medtronic
• Zimmer Biomet
• Orthofix
• RTI Surgical
• Xtant Medical
• Globus Medical
• Life Spine
• CoreLink
• VGI Medical
• SIGNUS Medizintechnik

Segment by Type

• Minimally Invasive Surgery
• Open Surgery of Sacroiliac Joint Fusion

Segment by Application

• Hospitals
• ASC

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of MIS Sacroiliac Joint Fusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of MIS Sacroiliac Joint Fusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of MIS Sacroiliac Joint Fusion in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 MIS Sacroiliac Joint Fusion Product Introduction
• 1.2 Global MIS Sacroiliac Joint Fusion Market Size Forecast
  • 1.2.1 Global MIS Sacroiliac Joint Fusion Sales Value (2020-2031)
  • 1.2.2 Global MIS Sacroiliac Joint Fusion Sales Volume (2020-2031)
  • 1.2.3 Global MIS Sacroiliac Joint Fusion Sales Price (2020-2031)
• 1.3 MIS Sacroiliac Joint Fusion Market Trends & Drivers
  • 1.3.1 MIS Sacroiliac Joint Fusion Industry Trends
  • 1.3.2 MIS Sacroiliac Joint Fusion Market Drivers & Opportunity
  • 1.3.3 MIS Sacroiliac Joint Fusion Market Challenges
  • 1.3.4 MIS Sacroiliac Joint Fusion Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global MIS Sacroiliac Joint Fusion Players Revenue Ranking (2024)
• 2.2 Global MIS Sacroiliac Joint Fusion Revenue by Company (2020-2025)
• 2.3 Global MIS Sacroiliac Joint Fusion Players Sales Volume Ranking (2024)
• 2.4 Global MIS Sacroiliac Joint Fusion Sales Volume by Company Players (2020-2025)
• 2.5 Global MIS Sacroiliac Joint Fusion Average Price by Company (2020-2025)
• 2.6 Key Manufacturers MIS Sacroiliac Joint Fusion Manufacturing Base and Headquarters
• 2.7 Key Manufacturers MIS Sacroiliac Joint Fusion Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of MIS Sacroiliac Joint Fusion
• 2.9 MIS Sacroiliac Joint Fusion Market Competitive Analysis
  • 2.9.1 MIS Sacroiliac Joint Fusion Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by MIS Sacroiliac Joint Fusion Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MIS Sacroiliac Joint Fusion as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Minimally Invasive Surgery
  • 3.1.2 Open Surgery of Sacroiliac Joint Fusion
• 3.2 Global MIS Sacroiliac Joint Fusion Sales Value by Type
  • 3.2.1 Global MIS Sacroiliac Joint Fusion Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global MIS Sacroiliac Joint Fusion Sales Value, by Type (2020-2031)
  • 3.2.3 Global MIS Sacroiliac Joint Fusion Sales Value, by Type (%) (2020-2031)
• 3.3 Global MIS Sacroiliac Joint Fusion Sales Volume by Type
  • 3.3.1 Global MIS Sacroiliac Joint Fusion Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global MIS Sacroiliac Joint Fusion Sales Volume, by Type (2020-2031)
  • 3.3.3 Global MIS Sacroiliac Joint Fusion Sales Volume, by Type (%) (2020-2031)
• 3.4 Global MIS Sacroiliac Joint Fusion Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 ASC
• 4.2 Global MIS Sacroiliac Joint Fusion Sales Value by Application
  • 4.2.1 Global MIS Sacroiliac Joint Fusion Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global MIS Sacroiliac Joint Fusion Sales Value, by Application (2020-2031)
  • 4.2.3 Global MIS Sacroiliac Joint Fusion Sales Value, by Application (%) (2020-2031)
• 4.3 Global MIS Sacroiliac Joint Fusion Sales Volume by Application
  • 4.3.1 Global MIS Sacroiliac Joint Fusion Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global MIS Sacroiliac Joint Fusion Sales Volume, by Application (2020-2031)
  • 4.3.3 Global MIS Sacroiliac Joint Fusion Sales Volume, by Application (%) (2020-2031)
• 4.4 Global MIS Sacroiliac Joint Fusion Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global MIS Sacroiliac Joint Fusion Sales Value by Region
  • 5.1.1 Global MIS Sacroiliac Joint Fusion Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global MIS Sacroiliac Joint Fusion Sales Value by Region (2020-2025)
  • 5.1.3 Global MIS Sacroiliac Joint Fusion Sales Value by Region (2026-2031)
  • 5.1.4 Global MIS Sacroiliac Joint Fusion Sales Value by Region (%), (2020-2031)
• 5.2 Global MIS Sacroiliac Joint Fusion Sales Volume by Region
  • 5.2.1 Global MIS Sacroiliac Joint Fusion Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global MIS Sacroiliac Joint Fusion Sales Volume by Region (2020-2025)
  • 5.2.3 Global MIS Sacroiliac Joint Fusion Sales Volume by Region (2026-2031)
  • 5.2.4 Global MIS Sacroiliac Joint Fusion Sales Volume by Region (%), (2020-2031)
• 5.3 Global MIS Sacroiliac Joint Fusion Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 5.4.2 North America MIS Sacroiliac Joint Fusion Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 5.5.2 Europe MIS Sacroiliac Joint Fusion Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 5.6.2 Asia Pacific MIS Sacroiliac Joint Fusion Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 5.7.2 South America MIS Sacroiliac Joint Fusion Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa MIS Sacroiliac Joint Fusion Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions MIS Sacroiliac Joint Fusion Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions MIS Sacroiliac Joint Fusion Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions MIS Sacroiliac Joint Fusion Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.3.2 United States MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.4.2 Europe MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.5.2 China MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.6.2 Japan MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.7.2 South Korea MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.8.2 Southeast Asia MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India MIS Sacroiliac Joint Fusion Sales Value, 2020-2031
  • 6.9.2 India MIS Sacroiliac Joint Fusion Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India MIS Sacroiliac Joint Fusion Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 SI-BONE
  • 7.1.1 SI-BONE Company Information
  • 7.1.2 SI-BONE Introduction and Business Overview
  • 7.1.3 SI-BONE MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 SI-BONE MIS Sacroiliac Joint Fusion Product Offerings
  • 7.1.5 SI-BONE Recent Development
• 7.2 Medtronic
  • 7.2.1 Medtronic Company Information
  • 7.2.2 Medtronic Introduction and Business Overview
  • 7.2.3 Medtronic MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Medtronic MIS Sacroiliac Joint Fusion Product Offerings
  • 7.2.5 Medtronic Recent Development
• 7.3 Zimmer Biomet
  • 7.3.1 Zimmer Biomet Company Information
  • 7.3.2 Zimmer Biomet Introduction and Business Overview
  • 7.3.3 Zimmer Biomet MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Zimmer Biomet MIS Sacroiliac Joint Fusion Product Offerings
  • 7.3.5 Zimmer Biomet Recent Development
• 7.4 Orthofix
  • 7.4.1 Orthofix Company Information
  • 7.4.2 Orthofix Introduction and Business Overview
  • 7.4.3 Orthofix MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Orthofix MIS Sacroiliac Joint Fusion Product Offerings
  • 7.4.5 Orthofix Recent Development
• 7.5 RTI Surgical
  • 7.5.1 RTI Surgical Company Information
  • 7.5.2 RTI Surgical Introduction and Business Overview
  • 7.5.3 RTI Surgical MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 RTI Surgical MIS Sacroiliac Joint Fusion Product Offerings
  • 7.5.5 RTI Surgical Recent Development
• 7.6 Xtant Medical
  • 7.6.1 Xtant Medical Company Information
  • 7.6.2 Xtant Medical Introduction and Business Overview
  • 7.6.3 Xtant Medical MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Xtant Medical MIS Sacroiliac Joint Fusion Product Offerings
  • 7.6.5 Xtant Medical Recent Development
• 7.7 Globus Medical
  • 7.7.1 Globus Medical Company Information
  • 7.7.2 Globus Medical Introduction and Business Overview
  • 7.7.3 Globus Medical MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Globus Medical MIS Sacroiliac Joint Fusion Product Offerings
  • 7.7.5 Globus Medical Recent Development
• 7.8 Life Spine
  • 7.8.1 Life Spine Company Information
  • 7.8.2 Life Spine Introduction and Business Overview
  • 7.8.3 Life Spine MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Life Spine MIS Sacroiliac Joint Fusion Product Offerings
  • 7.8.5 Life Spine Recent Development
• 7.9 CoreLink
  • 7.9.1 CoreLink Company Information
  • 7.9.2 CoreLink Introduction and Business Overview
  • 7.9.3 CoreLink MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 CoreLink MIS Sacroiliac Joint Fusion Product Offerings
  • 7.9.5 CoreLink Recent Development
• 7.10 VGI Medical
  • 7.10.1 VGI Medical Company Information
  • 7.10.2 VGI Medical Introduction and Business Overview
  • 7.10.3 VGI Medical MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 VGI Medical MIS Sacroiliac Joint Fusion Product Offerings
  • 7.10.5 VGI Medical Recent Development
• 7.11 SIGNUS Medizintechnik
  • 7.11.1 SIGNUS Medizintechnik Company Information
  • 7.11.2 SIGNUS Medizintechnik Introduction and Business Overview
  • 7.11.3 SIGNUS Medizintechnik MIS Sacroiliac Joint Fusion Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 SIGNUS Medizintechnik MIS Sacroiliac Joint Fusion Product Offerings
  • 7.11.5 SIGNUS Medizintechnik Recent Development

8 Industry Chain Analysis

• 8.1 MIS Sacroiliac Joint Fusion Industrial Chain
• 8.2 MIS Sacroiliac Joint Fusion Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 MIS Sacroiliac Joint Fusion Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 MIS Sacroiliac Joint Fusion Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer